The board of directors at Affinia Therapeutics is made up of individuals with a variety of backgrounds in both the medical and business fields. Most notably, the board consists of individuals who have been educated at some of the top institutions in the country, such as the University of California, San Francisco, Harvard Medical School, and the Massachusetts Institute of Technology. In addition, many members of the board have extensive experience working in the biotech and pharmaceutical industries, holding positions such as Chief Scientific Officer, Chief Investment Officer, and Vice President of Clinical Development and Medical Affairs. This combination of medical and business expertise provides Affinia with a well-rounded team that is able to make informed decisions about the direction of the company.
Aaron Tward
Scientific Co-Founder & Scient...
Botond Roska
Scientific Co-Founder & Scient...
Carole Faig
Board Member
Caroline Stout
Board Member
David Grayzel
Board Member
Diana M. Brainard
Board Member
Ed Mathers
Board Member
Elliott Sigal
Board Member
Luk Vandenberghe
Scientific Co-Founder & Scient...
Rick Modi
CEO & Board Member
Robert Weisskoff
Board Member
Sean P. Nolan
Chairman, Board of Directors
View all